Chagas disease mortality during the coronavirus disease 2019 pandemic: A Brazilian referral center experience

BACKGROUND: We investigated the mortality rates of patients with Chagas disease (CD) during the coronavirus disease 2019 (COVID-19) pandemic and assessed the association between this mortality and CD clinical presentation and comorbidities. METHODS: This was an observational retrospective study with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasslocher-Moreno, Alejandro Marcel, Saraiva, Roberto Magalhães, da Silva, Gilberto Marcelo Sperandio, Xavier, Sergio Salles, de Sousa, Andréa Silvestre, da Costa, Andrea Rodrigues, Mendes, Fernanda de Souza Nogueira Sardinha, Mediano, Mauro Felippe Felix
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Medicina Tropical - SBMT 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909444/
https://www.ncbi.nlm.nih.gov/pubmed/35239914
http://dx.doi.org/10.1590/0037-8682-0562-2021
Descripción
Sumario:BACKGROUND: We investigated the mortality rates of patients with Chagas disease (CD) during the coronavirus disease 2019 (COVID-19) pandemic and assessed the association between this mortality and CD clinical presentation and comorbidities. METHODS: This was an observational retrospective study with clinical data retrieved from medical records. RESULTS: Comorbidities were more prevalent among patients who died from COVID-19 than those who died from other causes. The proportion of patients according to CD clinical presentation was similar between the two groups. CONCLUSIONS: The prevalence of comorbidities seems to be related to a poorer prognosis in CD and COVID-19.

Ejemplares similares